3188 results for «911»

Filter By

3188 results

TAVI and alternative access

19 Feb 2023 – From PCR Tokyo Valves 2023

Learn more about TAVI in this session by reviewing case submissions on topics such as bailout transseptal approach, primary percutaneous transaxillary TAVI, and transapical TAVI with chimney stenting. 

Imaging for structural heart disease intervention

19 Feb 2023 – From PCR Tokyo Valves 2023

Consult this session if you want to learn about imaging in structural heart interventions by exploring series of slides on restoration post transcatheter mitral valve repair, diagnostic performance of CT angiography, and AI in aortic complex measurement for TAVI, and more! 

Other cardiac interventions

19 Feb 2023 – From PCR Tokyo Valves 2023

Explore innovative approaches to cardiac interventions featured at PCR Tokyo Valves 2023: from performing TricValve implantation in Asian patients to addressing unique cases like transcatheter valve replacement with a novel tricuspid bioprosthesis. Discover how these experts navigated challenging scenarios!

TAVI in patients with heavily calcified aortic root

19 Feb 2023 – From PCR Tokyo Valves 2023

What role does TAVI play in patients' severely calcified roots? Study the use of balloon-expandable devices, assessing the impact of calcification on aortic root rupture, strategies for safe and effective procedures, and when to consider surgical AVR.

Mitral valve implantation and other technology

19 Feb 2023 – From PCR Tokyo Valves 2023

This session offers insight into advanced mitral valve technologies. It covers details of transapical off-pump repair with synthetic chordae, India's success in transcatheter double valve-in-valve,  TMVI in failing valves, and more.

Coronary access after TAVI

19 Feb 2023 – From PCR Tokyo Valves 2023

Unlock insights into post-TAVI coronary access. Understand transcatheter aortic valve structure, neo-commissure anatomy, and practical techniques. This session covers topics such as optimising commissure alignment, elective CAG/PCI, ACS, and severe aortic stenosis.

The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial

25 Oct 2023

Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...

Nicola Ryan

Author

Nicola Ryan
Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement System in High-Risk Patients with Symptomatic Severe Native Aortic Regurgitation (ALIGN-AR)

30 years of primary PCI – a tale of perseverance

16 May 2023

Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.

30 years of primary PCI – a tale of perseverance
Didn’t find what you were looking for?